TSPO-mediated mitochondrial retrograde signaling primes the microglial NLRP3 inflammasome
Pharmacological Research · 2026-04 · 226 · 108145
DOI: 10.1016/j.phrs.2026.108145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacological Research, 2026-04. Verfasst von Aarti Singh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Biomedical Sciences, The Royal Veterinary College, University of London, London NW1 0TU, United Kingdom. Hauptthemen laut MEDLINE: Receptors, GABA, Microglia, Mitochondria, NLR Family, Pyrin Domain-Containing 3 Protein. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council BBSRC, BBSRC Biotechnology and Biological Sciences Research Council, Barts Charity.
Abstract (Originalsprache)
Uncontrolled microglial activation is a central driver of neuroinflammatory brain diseases. The mitochondrial translocator protein (TSPO) is a well-established molecular signature of brain inflammation and serves as a diagnostic marker. However, despite this strong association, it remains unclear whether TSPO acts as a positive or negative regulator of microglial function and how it influences the inflammatory and healing responses that follow brain injury. Moreover, recent evidence of species-specific differences in TSPO expression underscores the need to better define its biology in brain-resident macrophages. Here, using a murine microglial model, we demonstrate that TSPO is required for the mitochondrial priming of inflammation and acts as a conduit for its amplification. This function relies on the engagement of multiple intracellular pathways and can be effectively counteracted by the tricyclic indole compound GE-180. Specifically, in response to inflammatory stimuli, TSPO (i) stabilizes on the mitochondrial membrane where it binds and sequesters NOD-like receptor (NLR) proteins, (ii) represses PARK2-mediated mitophagy, and (iii) promotes nuclear retrograde signaling through NF-κB accumulation, thereby enhancing the expression of pro-inflammatory genes. Sustained TSPO-dependent inflammation further drives cellular demise and excitotoxicity. Collectively, these findings advance our understanding of TSPO's molecular physiology in microglia, highlight its pivotal role in mitochondrial control of inflammation, and identify TSPO as a promising target for the pharmacological modulation of neuroinflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Comparative Biomedical Sciences, The Royal Veterinary College, University of London, London NW1 0TU, United Kingdom.
- William Harvey Research Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom.
- William Harvey Research Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom; Department of Clinical, Pharmaceutical and Biological Science, University of Hertfordshire, Hatfield AL10 9AB, United…
- Barts Centre for Trauma Sciences, Blizard Institute, Queen Mary University of London, E1 2AT London, United Kingdom; Department of Clinical, Pharmaceutical and Biological Science, University of Hertfordshire, Hatfield A…
- Ataxia Centre, Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, Queen Square, London WC1N 3BG, United Kingdom.
- William Harvey Research Institute, Queen Mary University of London, EC1M 6BQ London, United Kingdom; CNRS UMR9018, Université Paris-Saclay, Gustave Roussy, Villejuif, France; Department of Biomedical Sciences, Universit…
Förderung
- Biotechnology and Biological Sciences Research Council BBSRC
- BBSRC Biotechnology and Biological Sciences Research Council
- Barts Charity
- ARC Foundation for Cancer Research
- H2020 European Research Council
- Italian Association for Cancer Research
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Singh, A., Rigon, M., Guo, T., Faccenda, D., Lakshmanan, G., Xia, D., Caldeira, M. G., Lopez-Tremoleda, J., Al-Khateeb, Z. F. H., Abeti, R., Giunti, P., & Campanella, M. (2026). TSPO-mediated mitochondrial retrograde signaling primes the microglial NLRP3 inflammasome. Pharmacological Research, 226, 108145. https://doi.org/10.1016/j.phrs.2026.108145
Vancouver
Singh A, Rigon M, Guo T, Faccenda D, Lakshmanan G, Xia D, et al. TSPO-mediated mitochondrial retrograde signaling primes the microglial NLRP3 inflammasome. Pharmacological Research. 2026;226:108145. doi:10.1016/j.phrs.2026.108145
BibTeX
@article{Singh2026,
author = {Singh, Aarti and Rigon, Manuel and Guo, Tong and Faccenda, Danilo and Lakshmanan, Gopinath and Xia, Dong and Caldeira, Marta Gramaça and Lopez-Tremoleda, Jordi and Al-Khateeb, Zahra Falah Hassan and Abeti, Rosella and Giunti, Paola and Campanella, Michelangelo},
title = {TSPO-mediated mitochondrial retrograde signaling primes the microglial NLRP3 inflammasome},
journal = {Pharmacological Research},
year = {2026},
volume = {226},
pages = {108145},
doi = {10.1016/j.phrs.2026.108145}
}
EUVIMED